Farmak refutes a fake about an overestimated price on a "triobrast" in a contract with a MIU military hospital and regards it as an attempt to discredit the Ukrainian manufacturer
The contract for the supply of drugs "Tombrast" was concluded with the MIU Main Military Clinical Hospital on March 27, 2025 under the procedure of proposals through Prozorro Market (ad: UA-2025-03-13-011363-A) in accordance with the current legislation. The agreement provided for the supply of 1100 pieces of ampoules of the drug. The price for one ampoule was 119. 40 UAH without VAT. Accordingly, the price for packaging (5 pieces in the box) - 597 UAH. Without VAT.
The maximum (reference) price registered with the Ministry of Health of Ukraine for this medicinal product is UAH 597. 45 without VAT. Publications stating that the purchase has taken place without a tender and at an inflated price are not true. The purchase was made in accordance with the resolution of 1178 kMU, which determines the order and list of goods obligatory for the purchase of health care facilities through Prozorro Market. Regarding the price: according to the data of the site Tabletki.
ua, the cost of "triobrast" in pharmacy networks ranges from 423. 72 UAH to 1070 UAH. The price of 423. 72 UAH is represented in only several pharmacies of the network "We wish health" throughout Ukraine, where 1-2 ampoules are available with a shelf life before 06. 2025. At the same time, on the official website of the pharmacy "We wish health" the price of the drug with a long shelf life is 857 UAH. Accordingly, pharmacies can form a price independently, including the shelf life.
And if it ends, pharmacies can do a discount to sell the product faster. A generalized analysis of prices for Tabletki. ua demonstrates that retail prices significantly exceed the maximum optic price approved by the Ministry of Health.
Therefore, the comparison of value within the state contract with the price of a product, which is presented in the pharmacy with one ampoule with almost exhausted shelf life is incorrect and indicates the superficiality of the analysis and lack of awareness of the author of the publication. Farmak calls for media representatives to comply with journalistic standards, to carefully check the information before publishing it and not to disseminate unbridled or distorted data.